HomeAstraZeneca gets EU backing for targeted breast cancer therapiesTablet bottles for AstraZeneca’s cancer drug Lynparza

Tablet bottles for AstraZeneca’s cancer drug Lynparza

Tablet bottles for AstraZeneca's cancer medicine Lynparza seen in an undated handout image provided to Reuters on June 27, 2022. AstraZeneca/Handout via REUTERS
FILE PHOTO: Exterior photos of the North America headquarters of
- Advertisment -
Google search engine

Most Read